Sentinel node biopsy after preoperative chemotherapy in breast carcinoma - Is it safe?

European Surgery - Acta Chirurgica Austriaca

Volumn 34, Issue 5, 2002, Pages 283-287

  Tausch, C ^a,b,c,d,e,f   Konstantiniuk, P ^a,b,c,d,e,f   Jorg L ^a,b,c,d,e,f   Dubsky, P ^a,b,c,d,e,f   Denison, Ursula ^a,b,c,d,e,f   Haid, A ^a,b,c,d,e,f   Pichler Gebhard, Barbara ^a,b,c,d,e,f   Rudas, Margaretha ^a,b,c,d,e,f  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^b Second Department of Surgery   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d GENERAL HOSPITAL LINZ   (Austria)

^e Landeskrankenhaus Feldkirch   (Austria)

^f Landeskrankenhaus V cklabruck ^*  (Austria)

Author keywords

Breast carcinoma; False negative rate; Preoperative chemotherapy; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PREOPERATIVE TREATMENT; SENTINEL LYMPH NODE BIOPSY;

EID: 0036965566     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2563.2002.02070.x     Document Type: Article

References (25)

1. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
2. Bonadonna G, Veronesi U, Brambilla C: Primary chemotherapy to avoid mastectomy in tumors of three centimeters or more. J Natl Cancer Inst 1990;80:1539-1545.
3. Breslin TM, Cohen LF, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. JCO 2000;18:3480-3484.
4. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA: Identifikation and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 2000;24:1266-1272.
5. Eary JF, Mankoff DA, Dunnwald LK, Byrd DR, Anderson BO, Yeung RS, Moe RE: Sentinel lymph node mapping for breast cancer: analysis in diverse patient group. Radiology 1999;213:526-529.
6. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Mora J, Escobedo A, Martin Comin J: Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nuclear Medicine Communications 2001;22:361-366.
7. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV: Effect of preoperative chemotherapy on local-regional disease in woman with operable breast cancer: findings from National Surgical Adjuvant Breast an Bowel Project B-18. J Clin Oncol 1997;15:2483-2489.
8. Giuliano AE, Jones RC, Brennan M, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
9. Goldie JH, Coldman AJ: A mathematical model for relating the drag sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
10. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, Breitfellner G, Sega W, Aufschnaiter M, Sturn H, Zimmermann G: Is Sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast cancer? Cancer 2001;92:1080-1084.
11. Julian TB, Patel N, Dusi D, Olson P, Nathan G, Janosz K, Isaacs G. Wolmark N: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J of Surg 2001;182:407-410.
12. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalisation of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
13. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941-946.
14. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE: Incidence and impact of documented eradication of breast cancer axillary lymph node metastasis before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999;230:72-78.
15. Mamounas EP, Brown A, Smith R, Julian T, Miller B, Anderson S, Bear H, Theoret H, Wickerham L, Wolmark N: Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: updated results from NSABP B-27, Am Society of Clin Oncol 2002:140.
16. McMasters KM, Wong SL, Martin RC II, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, Cerrito PB, Edwards MJ; University of Louisville Breast Cancer Study Group: Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676-687.
17. Minckwitz G, Dan Costa S, Eiermann W, Blohmer JU, Tulusan AH, Jachisch C et al.: Maximised reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol 1999;17:1999.
18. Nason KS, Anderson BO, Bird DA, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell KD, Yeung RS, Moe RE: Increased false negative sentinel node biopsy rates after preoperative chemotherapy. Cancer 2000;89:2187-2193.
19. O'Hea BJ, Hill ADK, El-Shirniny AM, Yeh SDH, Rosen PP, Coit DJ, Borgen PL, Cody HS: Sentinel lymph node biopsy in breast cancer initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
20. 99mTC-Labelled Colloid, Based on a Multicentre Database Project in Austria. Eur Surg 2002;34:272-276.
21. Rudas M, Konstantiniuk P, Horvat R, Niedermoser P, Bogner S, Pichler-Gebhard B, Hoffmann B, Offner F: Sentinel Lymph Node Examination: Balancing between High Workload and Low Metastasis Detection Rate. Eur Surg 2002;34:277-279.
22. Scholl SM, Forquet A. Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangie T, Jouve M, Beuzeboc P: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer 1994;30:645-652.
23. Steger GG, Wenzel C, Djavanmard MP, Gnant M, Jakesz R, Locker G, Taucher Set al.: Preoperative Docetaxel/Epidoxorubicin (DE) in primary breast cancer. Proc Am Society Clin Oncol 1999:448.
24. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:5-59.
25. Tafra L, Verbanac KM, Lannin DR: Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J of Surg 2001;182:312-315.